1. Çocuklarda Genişlemiş Spektrumlu Beta Laktamazlara (GSBL) Bağlı Üst Üriner Sistem Enfeksiyonunun Erken Tanısında CRP/Albümin Oranının (CAO) Kullanılması ve Üreyen Üropatojenler ile Antibiyotik Dirençleri.
- Author
-
GENÇLER, Aylin, YAKUT, Salim, and ZEYREK, Fadile YILDIZ
- Subjects
- *
ANTIBIOTICS , *URINE microbiology , *URINARY tract infections , *PREDICTIVE tests , *ENTEROCOCCUS , *EARLY medical intervention , *RECEIVER operating characteristic curves , *PROTEUS (Bacteria) , *DRUG resistance in microorganisms , *DESCRIPTIVE statistics , *ESCHERICHIA coli , *MEDICAL records , *ACQUISITION of data , *EARLY diagnosis , *DATA analysis software , *C-reactive protein , *SERUM albumin , *BIOMARKERS , *SENSITIVITY & specificity (Statistics) , *KLEBSIELLA , *CHILDREN - Abstract
Background: Urinary tract infections (UTIs) are the second most common infections among children. Early initiation of treatment is crucial to prevent complications. In recent years, the increasing production of extended-spectrum beta-lactamases (ESBL) in gram-negative bacteria has made it challenging to treat infections caused by these pathogens in children. The C-reactive protein to albumin ratio (CAR) has emerged as an important marker for inflammation in recent years. The aim of our study is to investigate the predictive value of CAR in the early identification of ESBL-positive upper urinary tract infections (UUTI) in children and to determine the antibiotic resistance profiles of isolated uropathogens. Materials and Methods: This study was conducted by reviewing the medical records of 194 children diagnosed with UUTI and treated either as outpatients or inpatients. Based on urine culture results, patients were divided into two groups: ESBL-positive UUTI and ESBL-negative UUTI. Laboratory tests obtained within the first 6 hours after UUTI diagnosis, before the initiation of antibiotic therapy, as well as demographic data, were retrieved from hospital records and compared between the two groups. The microorganisms isolated in urine cultures and their antimicrobial susceptibility results were recorded. Results: Of the patients, 98 (50,5%) were female and 96 (49,4%) were male, with a median age of 12 (4,92-36) months. Among the isolated pathogens, 126 (64,9%) were ESBL-negative, while 68 (35,1%) were ESBL-positive. CRP and CAR levels were significantly higher in the ESBL-positive UUTI group (p<0.001). A ROC analysis was performed to assess the ability of laboratory parameters to predict ESBL-positive UUTI. For CRP, values of 2,270 and above predicted ESBL positivity with 54,41% sensitivity and 61,11% specificity [p<0.001; AUC: 0.660 (0,584-0,737)]. For CAR, values of 0,698 and above predicted ESBLpositive UUTI with 58,82% sensitivity and 59,52% specificity [p=0.001; AUC: 0,650 (0,573-0,727)]. Escherichia coli (39,2%) was the most frequently isolated microorganism in all patients, followed by Klebsiella pneumoniae (28,9%), Enterococcus spp. (14,4%), and Proteus mirabilis (9,3%). Among ESBL-positive UUTI patients, the most commonly isolated microorganisms were E. coli and K. pneumoniae. Ampicillin resistance in ESBL-positive E. coli was 89,3%, and the highest resistance among cephalosporins was observed against ceftriaxone (89,7%). Amikacin resistance in ESBL-positive E. coli was 7,7%, while no resistance was observed in ESBL-positive UUTI K. pneumoniae. Meropenem resistance was found in 5,6% and ertapenem resistance in 6,7% of K. pneumoniae isolates, while in E. coli, meropenem resistance was 13,6% and ertapenem resistance was 9,1%. Conclusions: CAR is independently associated with ESBL-positive UUTI. Our study demonstrated that CAR may be useful in predicting ESBL-positive UUTI. Given the high resistance observed to cephalosporins, it is recommended that patients with significantly elevated CAR levels receive empirical treatment with carbapenems, amikacin, nitrofurantoin, or fosfomycin, whether treated as outpatients or inpatients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF